Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 2 | US | - | |
Diabetes Mellitus | Phase 2 | US | - | |
Diabetes Mellitus | Phase 2 | US | - | |
Alzheimer Disease | Preclinical | US | - | |
Alzheimer Disease | Preclinical | US | - | |
Alzheimer Disease | Preclinical | US | - | |
Diabetes Mellitus | Preclinical | US | - | |
Diabetes Mellitus | Preclinical | US | - |